Newron Pharmaceuticals (Italy)

262 papers and 14.2k indexed citations i.

About

In recent decades, authors affiliated with Newron Pharmaceuticals (Italy) have published 262 papers, which have received a total of 14.2k indexed citations. Scholars at this organization have produced 90 papers in Epidemiology, 80 papers in Molecular Biology and 56 papers in Immunology on the topics of Bacterial Infections and Vaccines (48 papers), Pneumonia and Respiratory Infections (44 papers) and Influenza Virus Research Studies (34 papers). Their work is cited by papers focused on Epidemiology (4.5k citations), Molecular Biology (4.1k citations) and Immunology (3.0k citations). Authors at Newron Pharmaceuticals (Italy) collaborate with scholars in Italy, United States and Germany and have published in prestigious journals including New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet. Some of Newron Pharmaceuticals (Italy)'s most productive authors include Rino Rappuoli, Audino Podda, Ennio De Gregorio, Guido Grandi, Derek T. O’Hagan, Ruggero G. Fariello, John L. Telford, Patricia Salvati, Anja Seubert and Sergio Abrignani.

In The Last Decade

Fields of papers published by authors at Newron Pharmaceuticals (Italy)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Newron Pharmaceuticals (Italy) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Newron Pharmaceuticals (Italy) at the time of their publication.

Countries citing scholars working at Newron Pharmaceuticals (Italy)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Newron Pharmaceuticals (Italy). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Newron Pharmaceuticals (Italy) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Newron Pharmaceuticals (Italy) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025